News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Biosciences, Inc. to Present at Upcoming 2013 Scientific Conferences


3/6/2013 7:03:05 AM

BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, today announced presentations at two upcoming scientific conferences:

•Nanomedicines Alliance Industry Symposium, March 6-7, 2013, Rockville, MD ? BIND will provide an oral presentation entitled “Managing Scale-up Challenges for Nanomedicines” in a session discussing Nanomedicine Chemistry Manufacturing and Controls.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES